Our in vitro and in vivo studies were performed with the established HCC cell lines, but the observations together with the previous clinical report [29–31] that high DEK abundance in HCC was strongly correlated with poor overall survival of HCC patients, suggesting a general oncogenic role of DEK in HCC development and progression. The gene discussed is DEK; the disease is hepatocellular carcinoma.